Business Wire

Energy Dome Inks a Strategic Commercial Agreement with Google

25.7.2025 07:00:00 CEST | Business Wire | Press Release

Share

Energy Dome, a pioneering company setting the benchmark for long-duration energy storage, has announced a global commercial partnership with Google using Energy Dome’s CO2 Battery technology to enable carbon-free energy for the grids that power Google’s operations. Alongside the commercial agreement, Google has made a strategic investment in Energy Dome.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250724389814/en/

Energy Dome’s CO2 Battery

Why Energy Dome and Google are partnering

Electricity is key to modern life and prosperity. This is increasingly relevant as the energy system is electrified, and economic growth drives new electricity demand, including from computational needs of artificial intelligence and data centers.

Solar and wind are amongst the most cost-effective and rapid ways of delivering capacity to the grid, but are inflexible due to their inherent intermittency. Long-duration energy storage resolves this flexibility constraint by storing solar and wind energy and dispatching it later when needed. For energy users such as Google, this technology enables “firm” electricity to meet demand in a reliable, clean, and cost-effective way.

Google’s first commercial long-duration energy storage deal is part of a growing portfolio of advanced energy technologies needed to realize its ambition to run its operations on 24/7 carbon-free energy by 2030. The selection of Energy Dome’s proven and market-ready CO2 Battery technology reflects its ability to be deployed at the scale, speed and affordability required on a global basis.

The CO2 Battery is capable of continuously dispatching energy for periods of 8 to 24 hours, unlocking enough firm electricity to meet both the baseload and flexibility requirements of large energy users. The modular, site-independent product design uses off-the-shelf equipment without supply chain bottlenecks, ensuring a highly scalable solution to store massive amounts of energy efficiently and cost-effectively.

Furthermore, the mechanical components of the technology help stabilize the grid by providing natural inertia from rotating machinery. This is especially important given the concurrent ramp-up of solar and wind (which lack inertia) with the ramp-down of legacy fossil-fuel power stations, whose inertia is lost when the plants are decommissioned. The CO2 Battery thus contributes to maintaining grid resiliency by acting as a shock absorber to smooth out sudden changes in frequency.

"Google is committed to powering our operations with clean energy, and Energy Dome's technologically proven and scalable long-duration energy storage solution can help us unlock rapid progress,” said Maud Texier, Director of EMEA Energy at Google. “But this isn’t just about Google. By helping to scale this first-of-a-kind LDES technology, we hope to help communities everywhere gain greater access to reliable, affordable electricity and support grid resilience as we integrate more renewable energy sources.”

The commercial agreement aims to develop CO2 Battery projects in all the key geographical strategic areas, including Europe, America, and the Asia-Pacific region, with the goal of scaling up deployment at a rapid pace to meet Google’s 2030 carbon-free energy goals. A pipeline of sites and projects has been identified in the partnership, which are currently in development and contracting stages.

“The programmatic and strategic deployment of our technology at scale to help Google reach carbon-free energy represents the core of our industry-first agreement. We’re proving that a 24/7 cost-effective and carbon-free energy supply is achievable with the right technology and partnership model,” said Claudio Spadacini, Founder and CEO of Energy Dome. “We are also pleased to welcome Google as an investor in Energy Dome, underlining our joint commitment to a shared vision.”

Investment Alongside Commercial Alliance

Beyondthe commercial collaboration, Google has also made an investment in Energy Dome. The investment coincides with the company entering a growth phase of commercial deployment, and multiple projects already contracted, including with Alliant Energy in the U.S., Engie in Italy, and NTPC in India.

By investing directly in the Milan-based scaleup, Google is reinforcing its long-term commitment to accelerating the commercialization of this proven technology. As a pioneer in the first generation of corporate power purchase agreements when solar and wind were in their infancy, Google brings both the customer perspective and experience to enhance the maturation and commercial scaling of CO2 Battery technology, unlocking adoption benefits for communities and economies.

About Energy Dome

Energy Dome is at the forefront of redefining long-duration energy storage with its CO2 Battery. The properties of carbon dioxide allow the system to store energy efficiently and cost-effectively through a patented thermo-mechanical process, hence representing the most valid alternative to lithium-ion batteries or pumped-hydro solutions. The CO2 Battery is already a fully validated and cost-effective system that uses no lithium or rare-earth elements to store electricity, boasting superior round-trip efficiency. With a modular approach and site-independent footprint, CO2 Batteries use readily available, off-the-shelf components from reliable, existing supply chains, providing a scalable pathway to store massive amounts of intermittent renewable energy and accelerate the energy transition; it’s the only technology available today offering the right combination of efficiency, cost, scalability and that’s viable globally. For more information, please visit energydome.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250724389814/en/

Contacts

Media Contact: Mario Torchio – m.torchio@energydome.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye